NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
26 hedge funds and large institutions have $19.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
O
1
OrbiMed
New York
|
$2.64M |
2 |
2
Squarepoint
New York
|
$449K |
3 |
3
Renaissance Technologies
New York
|
$2.72M |
4 |
PPCM
4
Pillar Pacific Capital Management
Pacifica,
California
|
$141K |
5 |
5
Jane Street
New York
|
$121K |